Medical technology company Vapotherm Inc. set terms for its initial public offering on Monday, saying in a regulatory filing that it plans to sell 4 million shares priced at $14 to $16 each. The company would raise $60 million at the midpoint of the range. The company has applied to list on the New York Stock Exchange under the ticker symbol "VAPO". BofA Merrill Lynch and William Blair are bookrunners on the deal with Canaccord and BTIG acting as co-managers. Vapotherm specializes in technology for patients suffering from respiratory distress.
This replaces an previous item that incorrectly reported the company's full name. It has been corrected.